Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership

13 hours ago 3
Sino Biopharmaceutical volition person $200 cardinal upfront from AstraZeneca, and volition beryllium eligible for milestone payments.
Read Entire Article